Case Study: Patient Remains Disease Free Five Years After Allogenic CAR T-Cell Therapy

by admin | Dec 30, 2025 | News & Opinions

By Cleveland Clinic – Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy A Cleveland Clinic patient participated in a clinical trial of allogenic CAR T-cell therapy to treat highly resistant multiple myeloma and...

To Bring Cell Culture into the Future, Consider Microenvironments

by admin | Dec 29, 2025 | News & Opinions

by James Lim, PhD – The Scientist – Let’s face it: Nobody pursues a career in science for the joy of culturing cells. But this thankless and time-intensive task is the backbone of biological research. When it’s done extremely well, the results generated...

UC Irvine receives million to test novel stem cell therapy for Huntington’s disease

UC Irvine receives $12 million to test novel stem cell therapy for Huntington’s disease

by admin | Dec 26, 2025 | News & Opinions

By UCI Health News – CIRM award will support first-of-its-kind clinical trial in humans This award will support a first-in-human safety and tolerability study of an embryonic stem cell-derived neural stem cell product for Huntington’s disease, a milestone for...

Novel surgical approach for retinal gene therapy shows promise

by admin | Dec 25, 2025 | News & Opinions

By Mayo Clinic – A Mayo Clinic study published in the September 2025 issue of Science Advances explores a novel approach to retinal gene therapy using fibrin hydrogels encapsulating adeno-associated virus 2-green fluorescent protein (AAV2-GFP). The findings...

The Best Biomarkers For Longevity, According To Experts

by admin | Dec 24, 2025 | News & Opinions

By Heidi Borst – Forbes – Human longevity has reached new heights. During the 20th century, lifespan in high-income countries increased by about 30 years due to public health and medicine advancements, according to a 2024 analysis in Nature Aging.[1] In...